Mark D Bartholomä (Mark Bartholomä)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Radical Prostatectomy

Prostate Cancer

Perovskite Solar Cells

Top Venues

Inorganic chemistry

Metallomics : integrated biometal science

This page only lists publications with an associated author ORCID identifier.

Publications

Moritz-Valentin Schreck, Caroline Burgard, Alexander Schmidtke, Ina Hierlmeier, Tobias Stemler, Stephan Maus, Florian Rosar, Martin Jung, Andreas Speicher, Samer Ezziddin, Jason P Holland, Mark D Bartholomä
Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68 Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. Molecular pharmaceutics (2023)
Caroline Alexandra Burgard, Florian Rosar, Robert J Marlowe, Mark D Bartholomä, Sebastian Dewes, Andrea Schaefer-Schuler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations. Cancers 15 (9) (2023)
Caroline Alexandra Burgard, Florian Rosar, Robert J Marlowe, Mark D Bartholomä, Sebastian Dewes, Andrea Schaefer-Schuler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations. Cancers 15 (9) (2023)
Ina Hierlmeier, Amaury Guillou, Daniel F Earley, Anthony Linden, Jason P Holland, Mark D Bartholomä
HNODThia: A Promising Chelator for the Development of 64 Cu Radiopharmaceuticals. Inorganic chemistry (2023)
Florian Rosar, Hanna Bader, Mark D Bartholomä, Stephan Maus, Caroline Alexandra Burgard, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [ 177 Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience. Cancers 14 (11) (2022)
Axia Marlin, Ina Hierlmeier, Amaury Guillou, Mark D Bartholomä, Pr Raphael Tripier, Véronique Patinec
Bioconjugated chelates based on (methylpyridinyl)tacn: synthesis, 64Cu labeling and in vitro evaluation for prostate cancer targeting. Metallomics : integrated biometal science 14 (6) (2022)
Florian Rosar, Robert Neher, Caroline Alexandra Burgard, Johannes Linxweiler, Mathias Schreckenberger, Manuela Andrea Hoffmann, Mark D Bartholomä, Fadi Khreish, Samer Ezziddin
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC. Cancers 14 (7) (2022)
Fadi Khreish, Mona Wiessner, Florian Rosar, Zaidoon Ghazal, Amir Sabet, Stephan Maus, Johannes Linxweiler, Mark D Bartholomä, Samer Ezziddin
Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Biomolecules 11 (8) (2021)
Sebastian Martin, Roswitha Tönnesmann, Ina Hierlmeier, Stephan Maus, Florian Rosar, Juri Ruf, Jason P Holland, Samer Ezziddin, Mark D Bartholomä
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617. Journal of medicinal chemistry 64 (8) (2021)
Fadi Khreish, Kalle Ribbat, Mark D Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT. Cancers 13 (16) (2021)
Tobias Stemler, Caroline Hoffmann, Ina M Hierlmeier, Stephan Maus, Elmar Krause, Samer Ezziddin, Gregor Jung, Mark D Bartholomä
A Structure-Activity Relationship Study of Bimodal BODIPY-Labeled PSMA-Targeting Bioconjugates. ChemMedChem 16 (16) (2021)
Sebastian Martin, Stephan Maus, Tobias Stemler, Florian Rosar, Fadi Khreish, Jason P Holland, Samer Ezziddin, Mark D Bartholomä
Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular imaging and biology 23 (1) (2020)
Alessandro Prestipino, Alica J Emhardt, Konrad Aumann, David O'Sullivan, Sivahari P Gorantla, Sandra Duquesne, Wolfgang Melchinger, Lukas M Braun, Slavica Vuckovic, Melanie Boerries, Hauke Busch, Sebastian Halbach, Sandra Pennisi, Teresa Poggio, Petya Apostolova, Pia Veratti, Michael Hettich, Gabriele Niedermann, Mark D Bartholomä, Khalid Shoumariyeh, Jonas Samuel Jutzi, Julius Wehrle, Christine Dierks, Heiko Becker, Annette Schmitt-Graeff, Marie Follo, Dietmar Pfeifer, Jan C Rohr, Sebastian Fuchs, Stephan Ehl, Frederike A Hartl, Susana Minguet, Christoph Cornelius Miething, Florian H Heidel, Nicolaus M Kröger, Ioanna Triviai, Tilman Brummer, Jürgen Finke, Anna L Illert, Eliana Ruggiero, Chiara Bonini, Justus Duyster, Heike Luise Pahl, Steven W Lane, Geoffrey R Hill, Bruce R Blazar, Nikolas von Bubnoff, Erika L Pearce, Robert Zeiser
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Science translational medicine 10 (429) (2019)
Mark D Bartholomä
Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application. Journal of labelled compounds & radiopharmaceuticals 61 (9) (2018)
Alexander Schmidtke, Tilman Läppchen, Christian Weinmann, Lorenz Bier-Schorr, Manfred Keller, Yvonne Kiefer, Jason P Holland, Mark D Bartholomä
Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms. Inorganic chemistry 56 (15) (2017)